Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-08-09FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a generic topical fluocinonide acetonide product under an original application from Padagis Israel Pharmaceuticals Ltd.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g [Phase 3]
Phase 3 trial update for Raptiva (efalizumab) in adults with psoriasis, focusing on plaque psoriasis, with the study having completed enroll…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies [Phase 4]
Phase 4 study evaluating Raptiva in combination with topical psoriasis therapies has completed in psoriasis patients. The update confirms tr…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis [NA]
A completed clinical trial evaluated the effect of a GLP-1 receptor agonist on psoriasis. The study status is reported as completed.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy [Phase 3]
A Phase 3 study evaluating efalizumab (Raptiva) in adults with moderate to severe plaque psoriasis who are candidates for systemic therapy h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-05-29Clinical Trial Update: TL1A Expression in Psoriatic Skin
A clinical trial update reports TL1A expression in psoriatic skin, with psoriasis as the condition; no status or results are provided.
-
CLINICAL_TRIALS trial_result · 2013-05-24Clinical Trial Update: Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis [Phase 4]
Phase 4 trial update evaluating the combination of narrow-band UVB phototherapy with etanercept for psoriasis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis [Phase 3]
A Phase 3 clinical trial update reports on the safety profile of etanercept 50 mg administered twice weekly in adults with psoriasis.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Enbrel® in Psoriatic Arthritis [Phase 4]
Phase 4 trial of Enbrel (etanercept) for psoriatic arthritis has completed (sponsor: Amgen).
-
CLINICAL_TRIALS research · 2013-05-06Clinical Trial Update: A Study to Assess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis.
A completed clinical study conducted in Spain to profile patients with moderate to severe psoriasis.
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects [Phase 3]
This update reports the completed Phase 3 safety evaluation of etanercept for psoriasis in adults.
-
FDA approval · 2013-04-04FDA Approved: ACITRETIN — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved the original application for Acitretin (generic) from Teva Pharmaceuticals USA, Inc., for the treatment of psoriasis.
-
FDA approval · 2013-04-04FDA Approved: ACITRETIN — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic acitretin (ACITRETIN) under an Original Application. This confirms the approval status for Teva's generic acitre…
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis [Phase 1]
Phase 1 trial update reporting on safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical effects of AMG 811 in s…
-
FDA approval · 2013-03-20FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for desoximetasone from Sun Pharmaceutical Industries, Inc., resulting in an updated approval for th…
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis [Phase 4]
Phase 4 trial update evaluating the immediate response to adalimumab and its impact on quality of life and comorbidity factors in adults wit…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris [Phase 2]
Phase 2 trial completion evaluating CT327 ointment for psoriasis vulgaris, reporting on efficacy, safety and tolerability.
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab [NA]
A completed clinical trial evaluating nurse education in subjects with psoriasis undergoing treatment with adalimumab, with results posted i…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206) [Phase 1]
Phase 1 study evaluating the effects of ustekinumab (Stelara) and etanercept (Enbrel) in adults with moderate to severe psoriasis; results w…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Efficacy Study of Dietary Intervention and Weight Loss in Improving Psoriasis [NA]
A completed clinical trial evaluated whether dietary changes and weight loss can improve psoriasis symptoms.
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis [Phase 1]
Pfizer completed a Phase 1 multiple-dose escalation study in medically stable subjects with psoriasis; results were posted in 2013.
-
FDA approval · 2013-02-05FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA's supplemental application for methotrexate, enabling the marketing of a generic methotrexate product…
-
CLINICAL_TRIALS withdrawal · 2013-01-24Clinical Trial Update: The Effect of Algae Dunaliella Bardawil on Psoriasis (2) [Phase 3]
A Phase 3 trial evaluating Dunaliella bardawil algae extract for psoriasis was withdrawn, with no results reported.
-
CLINICAL_TRIALS trial_result · 2013-01-22Clinical Trial Update: Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3 [Phase 2]
Phase 2 study evaluating the effects of oral vitamin D3 (cholecalciferol) in subjects with atopic dermatitis or psoriasis; results have been…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]
Phase 2 trial results evaluating ABT-874 for efficacy and safety in adults with moderate to severe chronic plaque psoriasis. The study is co…